Cargando…
The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer
SIMPLE SUMMARY: Late diagnosis and chemoresistance are key obstacles to ovarian cancer treatment success. Thus, there exists a need to develop new markers to detect ovarian cancer at an early stage as well as predict chemoresistance. We have developed a nanosensor platform that reacts with extracell...
Autores principales: | Asare-Werehene, Meshach, Hunter, Robert A., Gerber, Emma, Reunov, Arkadiy, Brine, Isaiah, Chang, Chia-Yu, Chang, Chia-Ching, Shieh, Dar-Bin, Burger, Dylan, Anis, Hanan, Tsang, Benjamin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177169/ https://www.ncbi.nlm.nih.gov/pubmed/37174032 http://dx.doi.org/10.3390/cancers15092566 |
Ejemplares similares
-
Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin
por: Gerber, Emma, et al.
Publicado: (2023) -
The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
por: Asare-Werehene, Meshach, et al.
Publicado: (2019) -
Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand
por: Chiu, Chen-Tzu, et al.
Publicado: (2020) -
Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes
por: Asare-Werehene, Meshach, et al.
Publicado: (2022) -
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
por: Onuma, Toshimichi, et al.
Publicado: (2022)